50-201-3726
Enzo Life Sciences Gefitinib-based PROTAC 3 (25mg). CAS: 2230821-27-7
Manufacturer: Enzo Life Sciences
CAS Number: 2230821-27-7
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | 50-201-3726-Each-of-1 | In Stock | ₹ 1,35,564.80 |
50-201-3726 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 1,35,564.80
GST (18%): ₹ 24,401.664
Total Price: ₹ 1,59,966.464
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | Medchemexpress LLC HY-123921 10mg , Gefitinib-based PROTAC 3 CAS:2230821-27-7 Purity:>98% | Medchemexpress LLC | ₹ 18,690.00 | |
 | Enzo Life Sciences Gefitinib-based PROTAC 3 (5mg). CAS: 2230821-27-7 | Enzo Life Sciences | ₹ 52,095.26 | |
| | Enzo Life Sciences Gefitinib-based PROTAC 3 (100mg). CAS: 2230821-27-7 | Enzo Life Sciences | ₹ 3,52,952.64 | |
| | Enzo Life Sciences Gefitinib-based PROTAC 3 (10mg). CAS: 2230821-27-7 | Enzo Life Sciences | ₹ 80,641.12 | |
| | Enzo Life Sciences Gefitinib-based PROTAC 3 (50mg). CAS: 2230821-27-7 | Enzo Life Sciences | ₹ 2,18,000.16 | |
 | Medchemexpress LLC HY-123921 5mg Medchemexpress, Gefitinib-based PROTAC 3 CAS:2230821-27-7 Purity:>98% | Medchemexpress LLC | ₹ 12,335.40 | |
 | Gefitinib-based PROTAC 3 | ChemScene | ₹ 11,748.00 - ₹ 19,580.00 | |
 | 2230821-27-7 | Gefitinib-based PROTAC 3 | A2B Chem | ₹ 1,869.00 - ₹ 27,234.00 |
Related Products